The Use of Medical Grade Honey in the Prevention of Bone Anchored Hearing Aid Associated Skin Breakdown
NCT03929224 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 17
Last updated 2026-01-07
Summary
Postoperative medicinal grade honey in post-operative care may prevent bone anchored hearing aid associated skin breakdown better than standard care of bacitracin ointment alone in adult patients.
Conditions
- Skin Infection
Interventions
- DRUG
-
Medicinal honey
Treat healing surgical site with medicinal honey
- DRUG
-
Bacitracin
Treat healing surgical site with bacitracin
Sponsors & Collaborators
-
Henry Ford Health System
lead OTHER
Principal Investigators
-
Seilesh Babu, MD · Michigan Ear Institute
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-10-25
- Primary Completion
- 2020-09-01
- Completion
- 2020-09-01
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Black Tea Compresses for Facial Eczema and Perioral Dermatitis
NCT02941432 ·Status: COMPLETED ·Phase: NA
-
Inpatient Penicillin Delabeling for Low-Risk Patients
NCT06414694 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
Monitoring Of Scratch Via Accelerometry In Children
NCT03873220 ·Status: COMPLETED
-
Effect of Providing Stratification of Low Risk Penicillin Allergies on Penicillin Allergy Label Removal in ICU Setting
NCT03702283 ·Status: COMPLETED ·Phase: NA
-
Ultrasonographic Response to Polarized Light Therapy in the Treatment of Atopic Dermatitis
NCT04955951 ·Status: TERMINATED
-
Effect of Tetrix on Alleviation of Burning,Itching Associated With Lesions of Contact Dermatitis
NCT00646867 ·Status: COMPLETED ·Phase: NA
-
The Effect of Providing Stratification of Low Risk Penicillin Allergies on Penicillin Allergy Label Removal
NCT03702270 ·Status: COMPLETED ·Phase: NA
-
Scratch Behavior Under Standard of Care
NCT03898427 ·Status: COMPLETED
-
Dermatitis During Adjuvant Irradiation for BREAst Cancer:
NCT06483477 ·Status: RECRUITING ·Phase: NA
-
A 47 Hour Occlusive Cutaneous Skin Patch Test on Adult Subjects With Dry/Atopic Skin
NCT02620293 ·Status: COMPLETED ·Phase: PHASE1
-
Applying Liquid Skin Barrier Film to Prevent Skin Complications Around Indwelling Vascular Catheters in Pediatric Patients: a Randomized Controlled Trial
NCT06192095 ·Status: COMPLETED ·Phase: NA
-
Cooling Pillow for Atopic Dermatitis
NCT01132651 ·Status: COMPLETED ·Phase: NA
-
Adding a Short Burst of Corticosteroid to the Conventional Treatment of H1 Antihistamines in Emergency Department.
NCT03296358 ·Status: COMPLETED ·Phase: NA
-
Scratching Validation Study
NCT05137093 ·Status: COMPLETED
-
Adding Auricular Acupuncture to Xiao-Feng-San Decoction for Treating Atopic Dermatitis
NCT06492902 ·Status: COMPLETED ·Phase: NA
-
Skin Health and Effectiveness of Standardized Skin Care Regimens in Nursing Home Residents
NCT02216526 ·Status: COMPLETED ·Phase: NA
-
Isocyanate Dermal Exposures in Autobody Shops
NCT00005552 ·Status: COMPLETED
-
HidraWear Study for Hidradenitis Suppurativa Wounds
NCT04449354 ·Status: COMPLETED ·Phase: NA
-
Insulin Sensitivity in Patients With Atopic Dermatitis
NCT03003793 ·Status: COMPLETED
-
Clinical Evaluation of Bacitracin
NCT00132600 ·Status: COMPLETED ·Phase: PHASE2
-
Compatibility of a Mild, Moisturizing Hand Cleanser for Patients With Mild to Moderate Hand Dermatitis
NCT00843466 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Efficacy and Safety of Enhanced External Counter-pulsation on Patients With Atopic Dermatitis and Inflammatory Skin Disease Requiring Wet Wrap Therapy
NCT06448702 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
An Open Label, Safety Study to Assess the Potential for Adrenal Suppression.
NCT02932891 ·Status: COMPLETED ·Phase: PHASE2
-
The Utility of Functionally Relevant Signature Genes in Assessing the Clinical Outcomes of Dupilumab Treatment
NCT04358224 ·Status: COMPLETED ·Phase: PHASE4
-
Moisturizing Effect of Two Dexpanthenol Formulations
NCT00839280 ·Status: COMPLETED ·Phase: PHASE2